Previous Page  11 / 30 Next Page
Information
Show Menu
Previous Page 11 / 30 Next Page
Page Background

Page 34

Notes:

conferenceseries

.com

October 26-27, 2016 Chicago, USA

Annual Congress on

Rare Diseases & Orphan Drugs

Volume 7, Issue 5 (Suppl)

J Genet Syndr Gene Ther

ISSN: 2157-7412 JGSGT, an open access journal

Rare Diseases 2016

October 26-27, 2016

Association between

FBN1

polymorphisms and TGF-β1 concentration within aneurysms and dissections

of ascending thoracic aorta

Ramune Sepetiene

Lithuanian University of Health Sciences, Lithuania

T

ransforming growth factor β1 (TGF-β1) is a cytokine that participates in a broad range of cellular regulatory processes and is

associated with various diseases including aortic aneurysm. An increased TGF-β1 level is associated with Marfan syndrome

(MFS) caused by fibrillin-1 (

FBN1

) mutations and subsequent defects in signaling system.

FBN1

single nucleotide polymorphisms

(SNPs) rs2118181 and rs1059177 do not cause MFS but are associated with dilatative pathology of ascending aorta. A purpose of

the investigation was to test hypothesis does an association between

FBN1

SNPs (rs2118181, rs1059177) and TGF-β1 level in human

blood plasma exist among sporadic cases of dilatative pathology of ascending aorta. A study group was recruited from 312 patients

who had undergone aortic reconstruction surgery due to dilatative pathology of ascending aorta and 741 healthy control subjects

of Kaunas population (N=269) without cardiovascular disorders, except hypertension. Genomic DNA was isolated from potassium

EDTA blood. Genotyping of

FBN1

SNPs was carried out by using ABI 7900HT Real-time PCR Thermocycler with commercially

available kits from Applied Biosystems. TGF-β1 quantitated detection was tested with eBioscience Platinum human TGF- β1 ELISA

commercially available kit based on standard sandwich enzyme-linked immune-sorbent assay technology according manufacturers’

instructions. Non-parametric Kruskal-Wallis test was used for data analysis. The results showed a quantitative dependence of SNP

genotype and TGF-β1 concentration. A presence of a single rs2118181 minor allele (G) increased the median amount of TGF-β1

level. Two copies of

FBN1

rs1059177 minor allele (G) were required to give a significant rise of TGF-β1 level in blood plasma. We also

found higher TGF-β1 concentrations in men compared to women (p=0.001). The results are indicating that presence of minor allele

of

FBN1

SNPs rs2118181 or presence of homozygous genotype of minor alleles of rs1059177 is associated with the significant increase

in TGF-β1 blood plasma level but the mechanism of this association is still unknown.

Biography

Ramune Sepetiene is currently a PhD Student at Lithuanian University of Health Sciences. She has obtained her MD with medical laboratory specialization in 1999

from Lithuanian University of Health Sciences, Medicine Academy. She has more than 15 years of clinical work experience within immunology, hematology and

genetics. She is a Junior Researcher in Laboratory of Molecular Cardiology, Institute of Cardiology, LUHS and part time laboratory MD position in patients’ clinic.

Recently she has published 4 papers within PhD dissertation subject in reputed journals of cardiac surgery and genetics.

 sepetiene@yahoo.co.uk

Ramune Sepetiene, J Genet Syndr Gene Ther 2016, 7:5 (Suppl)

http://dx.doi.org/10.4172/2157-7412.C1.009